NCT06123910

Brief Summary

32 recreational athletes who will attend to the Grand Marathon in the nort west of Mexico, event that will be held on December 2, 2018 or 21k Trail to be held in April 2019 will be invited to the study. Participants will be informed about the study procedures through a consent informed. Participants will be randomly divided into two groups, 16 in the intervention group and 16 in the comparison group. The participants will be recreational athletes between 18 and 60 years old. They must have athletic experience of at least 3 years. The participants considered will be those who perform vigorous physical activity per week according to the criteria of the short version IPAQ instrument. Smoking subjects with food intolerances and allergies, cardiovascular history will be excluded. Patients who have had a respiratory infection symptom in the last two weeks will not be able to participate in the study. Participants who are consuming some type of food supplement will be excluded. Two 18 ml of blood samples will be taken from the vein of the forearm by venipuncture of each participant, using K2EDTA tubes after and before supplementation period. Blood samples were taken before a corporal, aerobic and nutritional evaluations. CB supplementation will begin 4 weeks prior to competition events. One group will consume 20 g of bovine colostrum daily in solution with water. The second group will consume a placebo product with a nutritional composition similar to the group with the treatment of bovine colostrum. Both groups should take the supplement before breakfast with empty stomach.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 10, 2018

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 13, 2018

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 5, 2019

Completed
4.5 years until next milestone

First Submitted

Initial submission to the registry

October 16, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

November 9, 2023

Completed
Last Updated

November 9, 2023

Status Verified

November 1, 2023

Enrollment Period

1 month

First QC Date

October 16, 2023

Last Update Submit

November 3, 2023

Conditions

Outcome Measures

Primary Outcomes (8)

  • Neutrophil phagocytic capacity

    Percentage of phagocytic neutrophils

    Before and after 4 weeks of supplementation

  • Monocytes phagocytic capacity

    Percentage of phagocytic monocytes

    Before and after 4 weeks of supplementation

  • neutrophils producing reactive oxygen species

    percentage of positive cells to fluorescence intensity by flow cytometry

    before and after 4 weeks of supplementation

  • neutrophils reactive oxygen species production intensity

    Mean intensity fluorescent by cells measured by flow cytometry

    Before and after 4 weeks of supplementation

  • Monocytes producing reactive oxygen species

    percentage of positive cells to fluorescence intensity by flow cytometry

    before and after 4 weeks of supplementation

  • Monocytes reactive oxygen species production intensity

    Mean intensity fluorescent by cells measured by flow cytometry

    Before and after 4 weeks of supplementation

  • VO2Max

    Indicates participants aerobic condition (ml/kg/min)

    Before and after 4 weeks of supplementation

  • Days presenting upper respiratory tract symptoms

    Total of days that participants refers any kind of upper respiratory symptoms

    During supplementation 4 weeks of supplementation

Secondary Outcomes (6)

  • Weight

    before and after 4 weeks of supplementation

  • Height

    before and after 4 weeks of supplementation

  • Body fat

    before and after 4 weeks of supplementation

  • Fat free mass

    before and after 4 weeks of supplementation

  • Energy consumption

    before, after 2 and 4 weeks of supplementation

  • +1 more secondary outcomes

Study Arms (2)

Colostrum bovine

EXPERIMENTAL

Subjets taking a colostrum supplement

Dietary Supplement: Colostrum bovine

Placebo

PLACEBO COMPARATOR

Subjets taking a commercial dairy product

Other: Placebo

Interventions

Colostrum bovineDIETARY_SUPPLEMENT

Colostrum bovine supplements, 25 kcal per portion, containing 0.25 g fats, 2.0 g CHO and 3 g protein. Lactose reduced.

Also known as: sovereign laboratories colostrum ld powder
Colostrum bovine
PlaceboOTHER

Dairy comercial product. 25 kcal per portion, 1.3 g fats, 1.95 CHO and 1.3 protein. Lactose based.

Also known as: Milk powder
Placebo

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • at least 3 years of training experience
  • training for a half marathon competition
  • No smokers
  • Taking any kind of food supplements
  • No alimentary allergies

You may not qualify if:

  • Injuries
  • not follow experimental indications
  • cardiovascular disease
  • treatment intolerances

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro de Investigación en Alimentación y Desarrollo

Hermosillo, Sonora, 83304, Mexico

Location

Related Publications (18)

  • Hackney AC, Koltun KJ. The immune system and overtraining in athletes: clinical implications. Acta Clin Croat. 2012 Dec;51(4):633-41.

    PMID: 23540172BACKGROUND
  • Li TL, Gleeson M. The effect of single and repeated bouts of prolonged cycling on leukocyte redistribution, neutrophil degranulation, IL-6, and plasma stress hormone responses. Int J Sport Nutr Exerc Metab. 2004 Oct;14(5):501-16. doi: 10.1123/ijsnem.14.5.501.

    PMID: 15673097BACKGROUND
  • Peake J, Suzuki K. Neutrophil activation, antioxidant supplements and exercise-induced oxidative stress. Exerc Immunol Rev. 2004;10:129-41.

    PMID: 15633591BACKGROUND
  • Tritto ACC, Amano MT, De Cillo ME, Oliveira VA, Mendes SH, Yoshioka C, Roschel H, Camara NOS, Gualano B, Artioli GG. Effect of rapid weight loss and glutamine supplementation on immunosuppression of combat athletes: a double-blind, placebo-controlled study. J Exerc Rehabil. 2018 Feb 26;14(1):83-92. doi: 10.12965/jer.1835154.577. eCollection 2018 Feb.

    PMID: 29511657BACKGROUND
  • Bermon S, Castell LM, Calder PC, Bishop NC, Blomstrand E, Mooren FC, Kruger K, Kavazis AN, Quindry JC, Senchina DS, Nieman DC, Gleeson M, Pyne DB, Kitic CM, Close GL, Larson-Meyer DE, Marcos A, Meydani SN, Wu D, Walsh NP, Nagatomi R. Consensus Statement Immunonutrition and Exercise. Exerc Immunol Rev. 2017;23:8-50.

    PMID: 28224969BACKGROUND
  • Jones AW, Thatcher R, March DS, Davison G. Influence of 4 weeks of bovine colostrum supplementation on neutrophil and mucosal immune responses to prolonged cycling. Scand J Med Sci Sports. 2015 Dec;25(6):788-96. doi: 10.1111/sms.12433. Epub 2015 Feb 28.

    PMID: 25727914BACKGROUND
  • Shing CM, Peake J, Suzuki K, Okutsu M, Pereira R, Stevenson L, Jenkins DG, Coombes JS. Effects of bovine colostrum supplementation on immune variables in highly trained cyclists. J Appl Physiol (1985). 2007 Mar;102(3):1113-22. doi: 10.1152/japplphysiol.00553.2006. Epub 2006 Nov 9.

    PMID: 17095643BACKGROUND
  • Rathe M, Muller K, Sangild PT, Husby S. Clinical applications of bovine colostrum therapy: a systematic review. Nutr Rev. 2014 Apr;72(4):237-54. doi: 10.1111/nure.12089. Epub 2014 Feb 26.

    PMID: 24571383BACKGROUND
  • Crooks CV, Wall CR, Cross ML, Rutherfurd-Markwick KJ. The effect of bovine colostrum supplementation on salivary IgA in distance runners. Int J Sport Nutr Exerc Metab. 2006 Feb;16(1):47-64. doi: 10.1123/ijsnem.16.1.47.

    PMID: 16676703BACKGROUND
  • Soligard T, Steffen K, Palmer D, Alonso JM, Bahr R, Lopes AD, Dvorak J, Grant ME, Meeuwisse W, Mountjoy M, Pena Costa LO, Salmina N, Budgett R, Engebretsen L. Sports injury and illness incidence in the Rio de Janeiro 2016 Olympic Summer Games: A prospective study of 11274 athletes from 207 countries. Br J Sports Med. 2017 Sep;51(17):1265-1271. doi: 10.1136/bjsports-2017-097956. Epub 2017 Jul 29.

  • Palmer-Green D, Elliott N. Sports injury and illness epidemiology: Great Britain Olympic Team (TeamGB) surveillance during the Sochi 2014 Winter Olympic Games. Br J Sports Med. 2015 Jan;49(1):25-9. doi: 10.1136/bjsports-2014-094206. Epub 2014 Nov 25.

  • McCarthy DA, Macdonald I, Grant M, Marbut M, Watling M, Nicholson S, Deeks JJ, Wade AJ, Perry JD. Studies on the immediate and delayed leucocytosis elicited by brief (30-min) strenuous exercise. Eur J Appl Physiol Occup Physiol. 1992;64(6):513-7. doi: 10.1007/BF00843760.

  • Davison G, Diment BC. Bovine colostrum supplementation attenuates the decrease of salivary lysozyme and enhances the recovery of neutrophil function after prolonged exercise. Br J Nutr. 2010 May;103(10):1425-32. doi: 10.1017/S0007114509993503. Epub 2009 Dec 24.

  • Pyne DB, Baker MS, Fricker PA, McDonald WA, Telford RD, Weidemann MJ. Effects of an intensive 12-wk training program by elite swimmers on neutrophil oxidative activity. Med Sci Sports Exerc. 1995 Apr;27(4):536-42.

  • Robson PJ, Blannin AK, Walsh NP, Castell LM, Gleeson M. Effects of exercise intensity, duration and recovery on in vitro neutrophil function in male athletes. Int J Sports Med. 1999 Feb;20(2):128-35. doi: 10.1055/s-2007-971106.

  • Santos VC, Levada-Pires AC, Alves SR, Pithon-Curi TC, Curi R, Cury-Boaventura MF. Changes in lymphocyte and neutrophil function induced by a marathon race. Cell Biochem Funct. 2013 Apr;31(3):237-43. doi: 10.1002/cbf.2877. Epub 2012 Sep 13.

  • Brinkworth GD, Buckley JD. Concentrated bovine colostrum protein supplementation reduces the incidence of self-reported symptoms of upper respiratory tract infection in adult males. Eur J Nutr. 2003 Aug;42(4):228-32. doi: 10.1007/s00394-003-0410-x.

  • Crooks C, Cross ML, Wall C, Ali A. Effect of bovine colostrum supplementation on respiratory tract mucosal defenses in swimmers. Int J Sport Nutr Exerc Metab. 2010 Jun;20(3):224-35. doi: 10.1123/ijsnem.20.3.224.

MeSH Terms

Interventions

Refit milk powder

Study Officials

  • Jesús Hernández, PhD

    Centro de Investigación en Alimentación y Desarrollo A.C.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 16, 2023

First Posted

November 9, 2023

Study Start

October 10, 2018

Primary Completion

November 13, 2018

Study Completion

April 5, 2019

Last Updated

November 9, 2023

Record last verified: 2023-11

Locations